Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2
Journal of Agricultural and Food Chemistry · 2024
DOI: 10.1021/acs.jafc.3c07565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2024. Verfasst von Sunny Gupta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Plants, Medicinal, Plant Extracts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Indian Institute of Technology Delhi.
Abstract (Originalsprache)
Plants have a history of being employed in managing breast cancer. However, no scientific evidence supports the idea that these plants can effectively reduce the level of HER2 expression. In this study, extracts from 10 medicinal plants were evaluated for their anticancer properties against HER2-positive breast cancer cells through various methods, including the SRB assay, comet assay, annexin V-FITC dual staining, and immunoblotting. All extracts exerted antiproliferative activity against HER2-positive breast cancer cells. Furthermore, Terminalia chebula (T. chebula), Berberis aristata (B. aristata), and Mucuna pruriens (M. pruriens) reduced HER2 expression in tested cell lines. In addition, an increased Bax/Bcl-2 ratio was observed after the treatment. A comparative proteomics study showed modulation in the proteome profile of breast cancer cells after treatment with T. chebula, B. aristata, Punica granatum, M. pruriens, and Acorus calamus. Metabolic profiling of lead plants revealed the existence of multiple anticancer compounds. Our study demonstrates the considerable potential of the mentioned plants as innovative therapies for HER2-positive breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India.
- National Institute of Immunology, New Delhi 110067, India.
- CSIR Institute of Genomics and Integrative Biology, New Delhi 110025, India.
- All India Institute of Ayurveda Delhi, New Delhi 110076, India.
ORCID-Profile: Monica Sundd, Ashok Kumar Patel
Förderung
- Indian Institute of Technology Delhi
Zitieren
APA
Gupta, S., Prem, R., Sethy, C., Shrivastava, S., Singh, M., Yadav, P., Huddar, V. G., Prajapati, P. K., Roy, A., Sundd, M., & Patel, A. K. (2024). Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.3c07565
Vancouver
Gupta S, Prem R, Sethy C, Shrivastava S, Singh M, Yadav P, et al. Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2. Journal of Agricultural and Food Chemistry. 2024. doi:10.1021/acs.jafc.3c07565
BibTeX
@article{Gupta2024,
author = {Gupta, Sunny and Prem, Rashima and Sethy, Chinmayee and Shrivastava, Saurabh and Singh, Manju and Yadav, Pramod and Huddar, V G and Prajapati, P K and Roy, Anita and Sundd, Monica and Patel, Ashok Kumar},
title = {Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2},
journal = {Journal of Agricultural and Food Chemistry},
year = {2024},
doi = {10.1021/acs.jafc.3c07565}
}
EUVIMED